Why aren't Americans benefiting from customized treatment plans utilizing their specific genome types and targeting the unique needs of the problem? Advanced tests are out there but not enough patients are even getting tested, let alone, having the option of the correct tests!
Matt Brane helps break down some of the main reasons preventing these kinds of tests from reaching the average American patient. He is currently the Vice President of Managed Care at Guardant Health and has dedicated his career to helping people receive the treatment they deserve. His diverse background spans 20 years of professional development with expertise in market access and reimbursement strategy, sales and operations management, managed care/managed care management, business development, sales, and marketing in the Genomics, Oncology, Molecular Diagnostics, Medical Equipment, Specialty Pharmacy/Infusion, Physician and Hospital market.
Join us as we further discuss:
—----
Stay connected with our host, Perry Dimas, here on LinkedIn!
Why aren't Americans benefiting from customized treatment plans utilizing their specific genome types and targeting the unique needs of the problem? Advanced tests are out there but not enough patients are even getting tested, let alone, having the option of the correct tests!
Matt Brane helps break down some of the main reasons preventing these kinds of tests from reaching the average American patient. He is currently the Vice President of Managed Care at Guardant Health and has dedicated his career to helping people receive the treatment they deserve. His diverse background spans 20 years of professional development with expertise in market access and reimbursement strategy, sales and operations management, managed care/managed care management, business development, sales, and marketing in the Genomics, Oncology, Molecular Diagnostics, Medical Equipment, Specialty Pharmacy/Infusion, Physician and Hospital market.
Join us as we further discuss:
—----
Stay connected with our host, Perry Dimas, here on LinkedIn!